World

Women with PMOS should get subsidised weight loss drugs, advocates say

The Guardian Australia - World · 10 October 2026 at 10:00 am

Women with PMOS should get subsidised weight loss drugs, advocates say

With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-label Get our breaking news email , free app or daily news podcast Women living with a chronic hormonal condition should have access to taxpayer-funded weight loss medications, advocates say.

The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits Scheme for people living with the condition.

Read the full article on The Guardian Australia - World ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.theguardian.com — the content belongs to The Guardian Australia - World.

Women with PMOS should get subsidised weight loss drugs, advocates say

More from The Guardian Australia - World

Future of western security is at stake in Yemen civil war, says country’s former PM

French police accused over war-like injuries to teenagers in school protests

Sydney suburb Dulwich Hill in lockdown as police search for man seen with shotgun

Firearms manufacturer standing for One Nation in NSW opposes post-Bondi gun laws that ban his rifles

More in World

Future of western security is at stake in Yemen civil war, says country’s former PM

French police accused over war-like injuries to teenagers in school protests

Sydney suburb Dulwich Hill in lockdown as police search for man seen with shotgun

Boy, 16, kills three children and a teacher in Oregon school shooting

Ukraine’s latest battlefield drone is about to enter the kill zone – to fly out the wounded

Houthi missiles strike Yemen presidential palace, killing five